Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 May;2(3):322–324. doi: 10.1128/cdli.2.3.322-324.1995

Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus.

K Matsuda 1, H Tsutsumi 1, Y Okamoto 1, C Chiba 1
PMCID: PMC170153  PMID: 7664179

Abstract

Cytokine (interleukin 6 [IL-6] and tumor necrosis factor alpha [TNF-alpha]) activity in nasopharyngeal secretions of 21 infants and children (19 days to 16 months old) infected with primary respiratory syncytial virus was determined by an enzyme-linked immunosorbent assay. IL-6 and TNF-alpha were detectable in 100% (21 of 21) and 67% (14 of 21) of cases during the course of infection, respectively. Generally, TNF-alpha activity was high in the acute phase and declined thereafter, sometimes to undetectable levels. IL-6 activity was also highest in the acute phase and declined thereafter in infants younger than 5 months, while in patients older than 5 months, it-increased during the course of the disease to peak in the early convalescent phase. These observations suggest that inflammatory cytokines are produced in vivo in infants and children in response to primary respiratory syncytial virus infection and may be involved in disease pathogenesis. However, the mechanism of induction of cytokines may be different for infants and children in different age groups.

Full Text

The Full Text of this article is available as a PDF (164.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold R., Werner F., Humbert B., Werchau H., König W. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology. 1994 Jun;82(2):184–191. [PMC free article] [PubMed] [Google Scholar]
  2. Beagley K. W., Eldridge J. H., Lee F., Kiyono H., Everson M. P., Koopman W. J., Hirano T., Kishimoto T., McGhee J. R. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med. 1989 Jun 1;169(6):2133–2148. doi: 10.1084/jem.169.6.2133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Becker S., Quay J., Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol. 1991 Dec 15;147(12):4307–4312. [PubMed] [Google Scholar]
  4. Hayes P. J., Scott R., Wheeler J. In vivo production of tumour necrosis factor-alpha and interleukin-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virus. J Med Virol. 1994 Apr;42(4):323–329. doi: 10.1002/jmv.1890420402. [DOI] [PubMed] [Google Scholar]
  5. Hennet T., Ziltener H. J., Frei K., Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol. 1992 Aug 1;149(3):932–939. [PubMed] [Google Scholar]
  6. Kimman T. G., Westenbrink F. Immunity to human and bovine respiratory syncytial virus. Arch Virol. 1990;112(1-2):1–25. doi: 10.1007/BF01348982. [DOI] [PubMed] [Google Scholar]
  7. Midulla F., Villani A., Panuska J. R., Dab I., Kolls J. K., Merolla R., Ronchetti R. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis. 1993 Dec;168(6):1515–1519. doi: 10.1093/infdis/168.6.1515. [DOI] [PubMed] [Google Scholar]
  8. Morahan P. S., Connor J. R., Leary K. R. Viruses and the versatile macrophage. Br Med Bull. 1985 Jan;41(1):15–21. doi: 10.1093/oxfordjournals.bmb.a072017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mufson M. A., Belshe R. B., Orvell C., Norrby E. Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis. 1988 Jan;157(1):143–148. doi: 10.1093/infdis/157.1.143. [DOI] [PubMed] [Google Scholar]
  10. Murphy B. R., Graham B. S., Prince G. A., Walsh E. E., Chanock R. M., Karzon D. T., Wright P. F. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol. 1986 Jun;23(6):1009–1014. doi: 10.1128/jcm.23.6.1009-1014.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nagai K., Tsutsumi H., Yamazaki H., Pattamadilok S., Chiba S. Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in Japan. Arch Virol. 1993;128(1-2):55–63. doi: 10.1007/BF01309788. [DOI] [PubMed] [Google Scholar]
  12. Nathan C., Sporn M. Cytokines in context. J Cell Biol. 1991 Jun;113(5):981–986. doi: 10.1083/jcb.113.5.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Neilson K. A., Yunis E. J. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol. 1990;10(4):491–502. doi: 10.3109/15513819009067138. [DOI] [PubMed] [Google Scholar]
  14. Panuska J. R., Cirino N. M., Midulla F., Despot J. E., McFadden E. R., Jr, Huang Y. T. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest. 1990 Jul;86(1):113–119. doi: 10.1172/JCI114672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Panuska J. R., Hertz M. I., Taraf H., Villani A., Cirino N. M. Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):934–939. doi: 10.1164/ajrccm/145.4_Pt_1.934. [DOI] [PubMed] [Google Scholar]
  16. Panuska J. R., Midulla F., Cirino N. M., Villani A., Gilbert I. A., McFadden E. R., Jr, Huang Y. T. Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2. Am J Physiol. 1990 Dec;259(6 Pt 1):L396–L402. doi: 10.1152/ajplung.1990.259.6.L396. [DOI] [PubMed] [Google Scholar]
  17. Parrott R. H., Kim H. W., Arrobio J. O., Hodes D. S., Murphy B. R., Brandt C. D., Camargo E., Chanock R. M. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol. 1973 Oct;98(4):289–300. doi: 10.1093/oxfordjournals.aje.a121558. [DOI] [PubMed] [Google Scholar]
  18. Rodgers B. C., Mims C. A. Influenza virus replication in human alveolar macrophages. J Med Virol. 1982;9(3):177–184. doi: 10.1002/jmv.1890090304. [DOI] [PubMed] [Google Scholar]
  19. Tsutsumi H., Nagai K., Suga K., Chiba Y., Chiba S., Tsugawa S., Ogra P. L. Antigenic variation of human RSV strains isolated in Japan. J Med Virol. 1989 Feb;27(2):124–130. doi: 10.1002/jmv.1890270211. [DOI] [PubMed] [Google Scholar]
  20. Wong G. H., Goeddel D. V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. 1986 Oct 30-Nov 5Nature. 323(6091):819–822. doi: 10.1038/323819a0. [DOI] [PubMed] [Google Scholar]
  21. Yamazaki H., Tsutsumi H., Matsuda K., Nagai K., Ogra P. L., Chiba S. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. J Gen Virol. 1994 Aug;75(Pt 8):2115–2119. doi: 10.1099/0022-1317-75-8-2115. [DOI] [PubMed] [Google Scholar]
  22. Yamazaki H., Tsutsumi H., Matsuda K., Nagai K., Ogra P. L., Chiba S. Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection. Clin Diagn Lab Immunol. 1994 Jul;1(4):469–472. doi: 10.1128/cdli.1.4.469-472.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES